Literature DB >> 28302812

Developing an HIV vaccine.

Barton F Haynes1, Dennis R Burton2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28302812      PMCID: PMC5569908          DOI: 10.1126/science.aan0662

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  15 in total

Review 1.  Host controls of HIV broadly neutralizing antibody development.

Authors:  Garnett Kelsoe; Barton F Haynes
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

Review 2.  Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies.

Authors:  Laurent Verkoczy; Frederick W Alt; Ming Tian
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

Review 3.  Antibody responses to envelope glycoproteins in HIV-1 infection.

Authors:  Dennis R Burton; John R Mascola
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

4.  Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.

Authors:  Scott G Hansen; Jonah B Sacha; Colette M Hughes; Julia C Ford; Benjamin J Burwitz; Isabel Scholz; Roxanne M Gilbride; Matthew S Lewis; Awbrey N Gilliam; Abigail B Ventura; Daniel Malouli; Guangwu Xu; Rebecca Richards; Nathan Whizin; Jason S Reed; Katherine B Hammond; Miranda Fischer; John M Turner; Alfred W Legasse; Michael K Axthelm; Paul T Edlefsen; Jay A Nelson; Jeffrey D Lifson; Klaus Früh; Louis J Picker
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

Review 5.  New concepts in HIV-1 vaccine development.

Authors:  Kathryn E Stephenson; Helen T D'Couto; Dan H Barouch
Journal:  Curr Opin Immunol       Date:  2016-06-03       Impact factor: 7.486

Review 6.  Immune correlates of vaccine protection against HIV-1 acquisition.

Authors:  Lawrence Corey; Peter B Gilbert; Georgia D Tomaras; Barton F Haynes; Giuseppe Pantaleo; Anthony S Fauci
Journal:  Sci Transl Med       Date:  2015-10-21       Impact factor: 17.956

Review 7.  HIV-Host Interactions: Implications for Vaccine Design.

Authors:  Barton F Haynes; George M Shaw; Bette Korber; Garnett Kelsoe; Joseph Sodroski; Beatrice H Hahn; Persephone Borrow; Andrew J McMichael
Journal:  Cell Host Microbe       Date:  2016-02-25       Impact factor: 21.023

8.  Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques.

Authors:  Hui Li; Shuyi Wang; Rui Kong; Wenge Ding; Fang-Hua Lee; Zahra Parker; Eunlim Kim; Gerald H Learn; Paul Hahn; Ben Policicchio; Egidio Brocca-Cofano; Claire Deleage; Xingpei Hao; Gwo-Yu Chuang; Jason Gorman; Matthew Gardner; Mark G Lewis; Theodora Hatziioannou; Sampa Santra; Cristian Apetrei; Ivona Pandrea; S Munir Alam; Hua-Xin Liao; Xiaoying Shen; Georgia D Tomaras; Michael Farzan; Elena Chertova; Brandon F Keele; Jacob D Estes; Jeffrey D Lifson; Robert W Doms; David C Montefiori; Barton F Haynes; Joseph G Sodroski; Peter D Kwong; Beatrice H Hahn; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 12.779

Review 9.  Identification and specificity of broadly neutralizing antibodies against HIV.

Authors:  Laura E McCoy; Dennis R Burton
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

Review 10.  Native-like Env trimers as a platform for HIV-1 vaccine design.

Authors:  Rogier W Sanders; John P Moore
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

View more
  47 in total

1.  Shedding-Resistant HIV-1 Envelope Glycoproteins Adopt Downstream Conformations That Remain Responsive to Conformation-Preferring Ligands.

Authors:  Maolin Lu; Xiaochu Ma; Nick Reichard; Daniel S Terry; James Arthos; Amos B Smith; Joseph G Sodroski; Scott C Blanchard; Walther Mothes
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers.

Authors:  Rajesh P Ringe; Philippe Colin; Jonathan L Torres; Anila Yasmeen; Wen-Hsin Lee; Albert Cupo; Andrew B Ward; P J Klasse; John P Moore
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

3.  Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination.

Authors:  Archana V Boopathy; Anasuya Mandal; Daniel W Kulp; Sergey Menis; Nitasha R Bennett; Hannah C Watkins; Wade Wang; Jacob T Martin; Nikki T Thai; Yanpu He; William R Schief; Paula T Hammond; Darrell J Irvine
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

4.  Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations.

Authors:  Jacob T Martin; Christopher A Cottrell; Aleksandar Antanasijevic; Diane G Carnathan; Benjamin J Cossette; Chiamaka A Enemuo; Etse H Gebru; Yury Choe; Federico Viviano; Stephanie Fischinger; Talar Tokatlian; Kimberly M Cirelli; George Ueda; Jeffrey Copps; Torben Schiffner; Sergey Menis; Galit Alter; William R Schief; Shane Crotty; Neil P King; David Baker; Guido Silvestri; Andrew B Ward; Darrell J Irvine
Journal:  NPJ Vaccines       Date:  2020-08-05       Impact factor: 7.344

5.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

6.  A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop.

Authors:  Scott Sherrill-Mix; Kaleigh Connors; Grace M Aldrovandi; Jason M Brenchley; Charles Boucher; Frederic D Bushman; Ronald G Collman; Satya Dandekar; Nichole R Klatt; Laurel A Lagenaur; Roger Paredes; Gilda Tachedjian; Jim A Turpin; Alan L Landay; Mimi Ghosh
Journal:  AIDS Res Hum Retroviruses       Date:  2020-09-07       Impact factor: 2.205

7.  Optimizing immunization protocols to elicit broadly neutralizing antibodies.

Authors:  Kayla G Sprenger; Joy E Louveau; Pranav M Murugan; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

8.  Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models.

Authors:  Kevin O Saunders; Laurent K Verkoczy; Chuancang Jiang; Jinsong Zhang; Robert Parks; Haiyan Chen; Max Housman; Hilary Bouton-Verville; Xiaoying Shen; Ashley M Trama; Richard Scearce; Laura Sutherland; Sampa Santra; Amanda Newman; Amanda Eaton; Kai Xu; Ivelin S Georgiev; M Gordon Joyce; Georgia D Tomaras; Mattia Bonsignori; Steven G Reed; Andres Salazar; John R Mascola; M Anthony Moody; Derek W Cain; Mireille Centlivre; Sandra Zurawski; Gerard Zurawski; Harold P Erickson; Peter D Kwong; S Munir Alam; Yves Levy; David C Montefiori; Barton F Haynes
Journal:  Cell Rep       Date:  2017-12-26       Impact factor: 9.423

9.  Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles.

Authors:  Mariane Melo; Ely Porter; Yuan Zhang; Murillo Silva; Na Li; Brian Dobosh; Alessia Liguori; Pat Skog; Elise Landais; Sergey Menis; Devin Sok; David Nemazee; William R Schief; Ron Weiss; Darrell J Irvine
Journal:  Mol Ther       Date:  2019-08-19       Impact factor: 11.454

10.  Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.

Authors:  S Munir Alam; Kenneth Cronin; Robert Parks; Kara Anasti; Haitao Ding; Eden P Go; Heather Desaire; Amanda Eaton; David Montefiori; Joseph Sodroski; John Kappes; Barton F Haynes; Kevin O Saunders
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.